Probiotics in Mild Alzheimer's Disease

Status Recruiting

Clinical Trial Summary

The main objective is to investigate whether administration of probiotics to patients with mild Alzheimer's Disease (AD) reduces neuroinflammation, improves cognitive function and modifies neurophysiological measures, compared to a patient group that receives placebo (no active probiotics).

Clinical Trial Description

We will measure specific blood inflammatory markers (primary outcome), neurophysiological activity, cognitive test scores, microbiome composition and dietary habits of participants in the probiotics and placebo group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06181513
Study type	Interventional
Source	University of Nicosia
Contact	Nicoletta Nicolaou
Phone	+35722471903
Email	nicolaou.nic@unic.ac.cy
Status	Recruiting
Phase	Early Phase 1
Start date	December 19, 2022
Completion date	December 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05538455` - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases	N/A
Completed	`NCT05788133` - The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.	N/A
Completed	`NCT05080777` - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems	N/A
Completed	`NCT03295786` - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease	Phase 1/Phase 2
Recruiting	`NCT04265482` - Community-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
Not yet recruiting	`NCT02222779` - Quantification of Transition Metals	N/A
Recruiting	`NCT01291550` - Electronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath Samples	N/A
Completed	`NCT01450891` - Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease	N/A
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Recruiting	`NCT06148233` - CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging	N/A
Completed	`NCT03538522` - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831	Phase 2
Completed	`NCT06251830` - Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
Recruiting	`NCT04472130` - Neurodegenerative Diseases Registry
Completed	`NCT03353207` - Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration
Completed	`NCT05095870` - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Recruiting	`NCT05784090` - Correlation Between Melatonin Levels in Different Biological Fluids
Completed	`NCT02108769` - Yogic Breathing Changes Salivary Components	N/A
Recruiting	`NCT05508789` - A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)	Phase 3
Recruiting	`NCT04820881` - Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
Recruiting	`NCT05235802` - Long-term Follow-up in Severe Traumatic Brain Injury